TBATA

Across TCGA pan-cancer cohorts, TBATA RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated TBATA data layer compared with 4 for mutation status.

The strongest signal is observed in uveal melanoma (UVM), where higher TBATA RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TBATA expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

UVM, LUAD, and ACC are the cancer types where TBATA RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Quartile	All	0.494	0.796	<.001	45	view →
LUAD	DFS	Tertile	II,III,IV	0.770	0.329	<.001	40	view →
ACC	DFS	Tertile	II,III,IV	0.358	0.788	.014	30	view →
LIHC	OS	Tertile	All	0.684	0.823	.002	26	view →
LGG	DFS	Tertile	All	0.731	0.868	<.001	24	view →
HNSC	DFS	Median	IV	0.435	0.258	.002	19	view →
STAD	DFS	Quartile	All	0.294	0.784	.003	18	view →
MESO	OS	Tertile	All	0.466	0.575	.040	9	view →
PCPG	DFS	Tertile	All	0.630	0.875	.020	9	view →
LAML	DFS	Tertile	All	0.721	0.459	.013	8	view →
GBM	OS	Median	All	0.467	0.234	.004	6	view →
READ	OS	Median	II,III,IV	0.982	0.870	.014	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

TBATA–UVM (DFS)

Open the UVM breakdown →